Conditions

Study focuses on elevation of amylase and lipase levels as predictors of pancreatitis.

Dr. Scott Isaacs talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the differences in treating obesity in type 1 patients vs. type 2, and suggestions for medical professionals helping to treat a patient who needs to lose weight. Dr. Scott Isaacs, …

Dr. Scott Isaacs talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas to share how he chooses the best medication for a patient and his recommendation for how to successfully lose weight and maintain the loss. Dr. Scott Isaacs, MD, FACP, FACE is …

In a talk with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas, Dr. Scott Isaacs explains the importance of nutrition along with exercise in the treatment of obesity and the maintenance of weight loss. Dr. Scott Isaacs, MD, FACP, FACE is an endocrinologist and …

Dr. Scott Isaacs talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about endocrinology, obesity, and medical weight loss. Dr. Scott Isaacs, MD, FACP, FACE is an endocrinologist and adjunct instructor of Medicine at Emory University School of Medicine, Division of Endocrinology, Metabolism …

Youths who received any breastfeeding for at least 12 months or full breastfeeding for at least six months had lower odds of developing type 1 diabetes.

Besides lowering A1c, study finds success with using less insulin and weight reduction.

A low-risk intervention with potentially high rewards.

A proposed benefit of GLP-1 agonists confirmed in a human study.

Retrospective analysis presentation shows liraglutide (LIRA) improved glycemic parameters, reduced body weight, BMI, and waist circumference in new T2 patients.